Fluorescent bombesin-like peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S324000, C435S007100

Reexamination Certificate

active

07041642

ABSTRACT:
Light emitting compounds of the formula:where R1is a light-emitting moiety, R2is a bombesin-like peptide and fragment, derivative or analog thereof and L is a linker moiety, which may be present or absent. The peptide is linked at a first amino acid position to (C—X) which, in turn, is selected from the group including C═O, C═S, CH(OH), C═C=O, C═NH, CH2, CH(OR), CH(NR), CH(R), CR3R4, and C(OR3)OR4where R, R3, and R4are alkyl moieties or substituted alkyl moieties. Optionally the compound may include a linker moiety between the peptide and the C—X binding group. Preferably, the compound exhibits substantial biological activity in the presence of receptors having affinities for bombesin-like peptides.

REFERENCES:
patent: 4046633 (1977-09-01), Keutel
patent: 5248782 (1993-09-01), Haugland
patent: 5274113 (1993-12-01), Kang et al.
patent: 5693679 (1997-12-01), Vincent et al.
patent: 5760188 (1998-06-01), Beaudet et al.
patent: 27 02 699 (1977-12-01), None
patent: 3912046 (1990-03-01), None
patent: 0 007 407 (1980-02-01), None
patent: 0 240 914 (1987-10-01), None
patent: 0 333 071 (1988-11-01), None
patent: 0 331 126 (1989-09-01), None
patent: 0 466 565 (1992-01-01), None
patent: 0 606 804 (1994-07-01), None
patent: 0 608 987 (1994-08-01), None
patent: 2 291 708 (1996-01-01), None
patent: 63051400 (1988-03-01), None
patent: WO 93/04194 (1993-03-01), None
patent: WO 93/18068 (1993-09-01), None
patent: WO 95/22341 (1995-08-01), None
patent: WO 96/31531 (1996-10-01), None
patent: WO 97/04311 (1997-02-01), None
Fluorescently-labeled gastrin releasing peptide was first introduced as a product by the assignee, Advanced Bioconcept, Ltd., under the trade name Fluo-GRP™ on Nov. 10, 1997.
Fluorescently-labeled neuromedin-C was first introduced as a product by the assignee, Advanced Bioconcept, Ltd., under the trade name Fluo-NMC™ on Feb. 10, 1998.
Amoscato et al., “Synthesis of Two Biologically Active Fluorescent Probes of Thymopentin”Peptide Protein Res., 29:177-186 (1987).
Ashworth et al., “Visualization of the Thyropoin-releasing Hormone Receptor And Its Ligand During Endocytosis And Recycling”Proc. Nat'l. Acad. Sci. USA, 92:512-516 (1995).
Beaudet et al., “Internalization And Intracellular Mobilization Of Neurotensin In Neuronal Cells”Biochemical Pharmacology, 47:43-52 (1994).
Beaudet et al., “Annales d'endocrinologie” p. L14, Sep. 1-3, 1994 (conference date).
Bowden et al., “Direct Observation of Substance P-induced Internalization of Neurokinin 1 (NK1) Receptors at Sites of Inflammation”Proc. Nat'l. Acad. Sci. USA, 91:8964-8968 (1994).
Bunnett et al., “Characterization Of Receptors Using Cyanine 3-labeled Neuropeptides”Peptides, 16:733-740, (1995).
Cardullo et al., “Speract Receptors Are Localized on Sea Urchin Sperm Flagella Using a Fluorescent Peptide Analog”Developmental Biology, 162:600-607 (1994).
Carraway et al., “The Isolation of a New Hypotensive Peptide, Neurotensin, From Bovine Hypothalami”J. of Biological Chemistry, 248:6854-6861 (1973).
Cauvin et al., “Properties and Distribution of Receptors For Pituitary Adenylate Cyclase Activating Peptide (PACAP) In Rat and Spinal Cord”Regulatory Peptides, 35:161-173 (1991).
Chard, Laboratory Techniques in Biochemistry and Molecular Biology, Elzevier Biomedical Press, New York.
Cheng et al., “Fluorescent Rhodamine-Labeled Thyroid Hormone Derivatives”FEBS Letters, 100:113-116 (1979).
Cheng et al., “Receptor-mediated Uptake Of 3,3′5-triiodo-L-thyronine By Cultured Fibroblasts”Proc. Nat'l. Acad. Sci. USA, 77:3425-3429 (1980).
Chersi et al., “Preparation And Utilization Of Fluorescent Synthetic Peptides”Biochemica et Biophysica Acta, 1034:333-336 (1990).
Christophe, “Type I Receptors For PACAP (A Neuropeptide Even More Important Than VIP?)”Biochimica et Biophysica Acta, 1154:183-199 (1993).
Cushman, “Spectrophotometric Assay And Properties Of the Angiotensin-converting Enzyme of Rabbit Lung”Biochemical Pharmacology, 20:1637-1648 (1971).
Epelbaum, “Somatostatin Receptors In the Central Nervous System”Basic and Chemical Aspects of Neuroscience, 4:17-28 (1992).
Faure et al., “Binding and Internalization of Neurotensin In Hybrid Cells Derived From Septal Cholinergic Neuronsα”Annals of the New York Academy of Sciences, 668:345-347 (1992).
Faure et al., “Synthesis of a Biologically Active Fluorescent Probe For Labeling Neurotensin Receptors”The Journal of Histochemistry and Cytochemistry, 42:755-763 (1994).
Garland et al., “Agonist-induced Internalization Of the Substance p (NK1) Receptor Expressed in Epithelia Cells”Biochem. J., 303:177-186 (1994).
Grady et al., “Delineation of the Endocytic Pathway of Substance P and Its Seven-Transmembrane Domains NK1 Receptor”Molecular Biology of the Cell, 6:509-524 (1995).
Grady et al., “Direct Observation Of Endocytosis Of Gastrin Releasing Peptide And Its Receptor”J. of Biol. Chem., 270:4603-04611 (1995).
Goldstein et al., “DAKLI: A Multipurpose Ligand With High Affinity And Selectivity For Dynorphin (kappa opioid) Binding Sites”Proc. Nat'l Acad. Sci., 85:7375-7379 (1988).
Guillon et al., “Lateral Mobility of the Phospholipase C-activating Vasopressin V1-type Receptor In A7r5 Smooth Muscle Cells: A Comparison With the Adenylate Cyclase-Coupled V2-receptor”Peptides, 13:7-11 (1992).
Haigler et al., “Visualization By Fluorescence of the Binding and Internalization of Epidermal Growth Factor In Human Carcinoma Cells A-431”Proc Natl Acad Sci USA, 75:3317-3321 (1978).
Haugland et al.,Noninvasive Techniques In Cell Biology, Wiley-Liss, Inc. (1990).
Haugland,Handbook of Fluorescent Probes and Research Chemicals—5thedition (1992).
Hazum et al., “Cluster Formation of Opiate (enkephalin) Receptors In Neuroblastoma Cells: Differences Between Agonists And Antagonists And Possible Relationships To Biological Functions”Proc. Nat'l. Acad. Sci., 77:3038-3041 (1980).
Hazum et al., “Fluorescent And Photo-affinity Enkephalin Derivatives: Preparation And Interaction With Opiate Receptors”Biochemical And Biophysical Research Communications, 88:841-846 (1979).
Jans et al., “Lateral Mobility of the Phospholipase C-activating Vasopressin V1-type Receptor In A7r5 Smooth Muscle Cells: A Comparison With the Adenylate Cyclase-coupled V2-Receptor”EMBO Journal, 9:2693-2699, (1990).
Kitabgi et al., (eds),Annals NY Acad. Sci., 668:Table of Contents.
Kohzuki et al., “Localization And Characterization of Endothelin Receptor Binding Sites In the Rat Brain Visualized ByIn VitroAutoradiography”Neuroscience, 42:245-260 (1991).
Maxfield, “Fluorescent Analogs Of Peptides And Hormones”Methods in Cell Biology, 29:13-28 (1989).
Melander et al.,125I-Galanin Binding Sites In the Rat Central Nervous SystemHandbook of Chemical Neuroanatomy, vol. II, Elsevier Publishers (1992).
Merchenthaler et al., “Anatomy And Physiology of Central Galanin-containing Pathways”Prog. Neurobiol., 40:711-769 (1993).
Nawa et al., “Nucleotide Sequences of Cloned cDNAs For Two Types of Bovine Brain Substance P Prescursor”Nature, 306:32-36 (1983).
Niedel et al., “Receptor-mediated Internalization of Fluorescent Chemotactic Peptide By Human Neutrophils”Science, 205:1412-1414 (1979).
Rivier, et al., “D-Trp8-somatostatin: An Analog Of Somatostatin More Potent Than the Native Molecule”Biochemical and Biophysical Research Communications, 65:746-751 (1975).
Roettger, et al., “Insulation Of A G Protein-coupled Receptor On the Plasmalemmal Surface Of the Pancreatic Acinar Cell”J. Cell Biol., 130: 579-590 (1995).
Rubanyi et al., “Endothelins: Molecular Biology, Biochemistry, Pharmacology, Physiology, And Pathophysiology”Pharmacological Reviews

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fluorescent bombesin-like peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fluorescent bombesin-like peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorescent bombesin-like peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3586653

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.